Keep a listing of all of your drugs along with you, and share the listing along with your doctor and pharmacist. Examine together with your doctor When you have wellbeing thoughts or worries.
butabarbital will minimize the level or result of paclitaxel protein certain by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minimal/Significance Not known.
butabarbital will lower the level or impact of almotriptan by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Check.
butabarbital will reduce the extent or influence of nimodipine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Not known.
butabarbital decreases levels of amphotericin B deoxycholate by inhibition of GI absorption. Applies only to oral kind of each brokers. Slight/Significance Not known.
butabarbital will reduce the extent or effect of pitolisant by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Watch Carefully. Pitolisant exposure is decreased by 50% if coadministered with strong CYP3A4 inducers.
butabarbital will reduce the extent or outcome of parecoxib by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Small/Significance Unknown.
Barbiturates may well impair psychological and/or physical qualities needed with the performance of potentially hazardous tasks, like driving or functioning equipment.
butabarbital will minimize the extent or result of cocaine topical by influencing hepatic enzyme CYP2B6 metabolism. Insignificant/Importance Unidentified.
butabarbital will lower the level or effect of isradipine by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Slight/Significance Unfamiliar.
butabarbital will reduce the extent or impact of tolterodine by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep an eye on.
butabarbital will minimize the level or effect of duvelisib by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Stay clear of or Use Alternate Drug. Coadministration with a strong more info CYP3A inducer decreases duvelisib area under the curve (AUC), which can lessen duvelisib efficacy.
butabarbital will minimize the extent or result of sunitinib by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Observe.
butabarbital will decrease the level or effect of lonafarnib by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Lonafarnib is actually a delicate CYP3A4 substrate. Coadministration with strong or moderate CYP3A4 inducers is contraindicated.